Myriam Curet Sells 408 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Intuitive Surgical Stock Down 0.3 %

Shares of Intuitive Surgical stock opened at $589.61 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $210.01 billion, a PE ratio of 91.98, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The business has a fifty day simple moving average of $556.91 and a 200-day simple moving average of $516.98.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, Mizuho upped their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $2,401,493,000. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. International Assets Investment Management LLC boosted its stake in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares during the period. Proficio Capital Partners LLC increased its stake in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Finally, FMR LLC raised its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.